The role of support groups, advocacy groups, and other interested parties in improving the care of patients with congenital adrenal hyperplasia: pleas and warnings.
AbstractIn the era of advocacy groups, it seems appropriate to contemplate how best to utilize them for patient benefit in the management of those with disorders of sex development (DSD), including those with congenital adrenal hyperplasia (CAH). Such interactions, to be constructive, require a spirit of cooperation to optimize outcomes. A traditional view of advocacy groups as a type of defender of patients' rights appears outdated and it is time that the benefits of their participation be fully realized. Open dialogue with all patients/families, including those who feel harmed by prior care are paramount. We discuss several recent examples of interactions that illustrate how dialogue in the name of "advocacy" can have a negative impact on developing a framework for ongoing constructive dialogue and actions. Such approaches completely change the dynamics of subsequent interactions. Physicians involved in the care of individuals with DSD, including those with CAH, and patients should be aware of confrontational techniques and legal implications that may be used by some advocacy groups. Hopefully recent efforts to promote a multidisciplinary care approach for patients with DSD/CAH will continue to foster mutual cooperation between team members, where the common goal is improving patient/family outcomes and quality of life.
CitationInt J Pediatr Endocrinol. 2010 Jun 23; 2010:563640
- Congenital adrenal hyperplasia patient perception of 'disorders of sex development' nomenclature.
- Authors: Lin-Su K, Lekarev O, Poppas DP, Vogiatzi MG
- Issue date: 2015
- Integration of child life services in the delivery of multi-disciplinary differences in Sexual Development (DSD) and Congenital Adrenal Hyperplasia (CAH) care.
- Authors: Cheng JW, McCauley E, Nicassio LN, Fechner PY, Amies Oelschlager AE, Adam MP, Fisher C, Wetzler J, Kinsinger R, Nelson P, McCune N, Cain MP, Shnorhavorian M
- Issue date: 2022 Aug 18
- Should we question early feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype?
- Authors: Binet A, Lardy H, Geslin D, Francois-Fiquet C, Poli-Merol ML
- Issue date: 2016 Mar
- Research on quality of life in female patients with congenital adrenal hyperplasia and issues in developing nations.
- Authors: Zainuddin AA, Grover SR, Shamsuddin K, Mahdy ZA
- Issue date: 2013 Dec
- The future of Cochrane Neonatal.
- Authors: Soll RF, Ovelman C, McGuire W
- Issue date: 2020 Nov